Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_assertion type Assertion NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_head.
- NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_assertion description "[Of the cytology-positive lymph nodes (27 lymph nodes), the expression of the KS1/4 gene was above its respective clinical threshold in 25 of 27 samples (93%), making this the most sensitive marker for the detection of metastatic NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_provenance.
- NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_assertion evidence source_evidence_literature NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_provenance.
- NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_assertion SIO_000772 15705978 NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_provenance.
- NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_assertion wasDerivedFrom befree-20140225 NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_provenance.
- NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_assertion wasGeneratedBy ECO_0000203 NP589132.RAmmFvFLYWhpk7g2rX4I9XkxB4Tc1SZh3-vvwF5xknUB0130_provenance.